Pediatric patients with noninfectious uveitis demonstrate a nearly 7-fold increased risk for developing first-time immune-mediated inflammatory disease vs. the general population, according to data published in JAMA Network Open.
“Pediatric uveitis is frequently associated with immune-mediated inflammatory diseases (IMIDs); however, population-level estimates of IMID risk and immunosuppressant use are
limited, as existing evidence is largely derived from tertiary-center cohorts with substantial
referral bias,” Jay Jiyong Kwak, MD, from the Institute of Vision Research at Yonsei

Pediatric patients with noninfectious uveitis demonstrate a nearly 7-fold increased risk for developing first-time immune-mediated inflammatory disease vs. the general population, according to data published in JAMA Network Open.
“Pediatric uveitis is frequently associated with immune-mediated inflammatory diseases (IMIDs); however, population-level estimates of IMID risk and immunosuppressant use are
limited, as existing evidence is largely derived from tertiary-center cohorts with substantial
referral bias,” Jay Jiyong Kwak, MD, from the Institute of Vision Research at Yonsei